Which GLP-1 drugs show blood pressure benefits
Foundational Research The foundational work in the 1980s by researchers including Guillemin, Rivier, and others established that synthetic GRF(1-29)-NH2 (Sermorelin) possesses full biological activity for stimulating GH release equivalent to the full 44-amino acid GHRH, validating the concept that only the N-terminal 29 amino acids are required for receptor binding and activation
When Do You Inject Tesamorelin/Ipamorelin
Beyond its FDA-approved use, it is increasingly studied for its potential in anti-aging medicine, improving energy, cognitive function, and muscle preservation as people age.* Patients seeking Tesamorelin therapy may benefit from reduced central fat, enhanced metabolism, and support in maintaining lean body mass, making it a promising option for individuals focused on long-term wellness and vitality.* Reduction in Visceral Fat: Tesamorelin is one of the few therapies clinically validated to specifically target visceral fat, which is associated with cardiovascular disease, insulin resistance, and inflammatory markers
Proc Natl Acad Sci USA 108(21):86748679
Research by Duan et al